Skip to main content
Pandemics, Patents, and Price Controls
Researchers at the UW Medicine Retrovirology Research Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trial on February 12, 2021 in Seattle, Washington
(Photo by Karen Ducey/Getty Images)

Pandemics, Patents, and Price Controls

Adam Mossoff


The COVID-19 pandemic has shown the world what decades of patent protection has made possible in the biopharmaceutical sector of the U.S. innovation economy. Nonetheless, price controls now threaten to stifle this innovation. If the government twists its own laws and arbitrarily imposes price controls on patented vaccines and drugs created by pharmaceutical innovators, innovation will not occur. Statist price controls kill innovation, destroy markets, and stymie or degrade economic development. We should prevent politicians and activists from exploiting the COVID-19 crisis to undermine both patents and biopharmaceutical advancement—harming people today and preventing an effective response to the next pandemic.

Read the full report in Heritage Foundation

Related Articles

We Need a Comprehensive Commission on COVID-19

Arthur Herman

There’s a growing clamor on Capitol Hill and elsewhere for creation of an independent body similar to the Robb-Silberman or 9/11 commissions to look...

Continue Reading

The Push For Another WHO Probe on COVID Origins

David Asher

In an interview on America’s Newsroom on Fox News, David Asher discusses the Wuhan lab leak. ...

Watch Now

Transcript: Uncovering the Origins of COVID-19: A Scientific Discussion

David Asher

Following is the full transcript of the June 16th, 2021 Hudson event titled Uncovering the Origins of COVID-19: A Scientific Discussion ...

Continue Reading